GC1008

Known as: Anti-TGF-Beta Monoclonal Antibody GC1008, Human Anti-TGF-Beta Monoclonal Antibody GC1008, Immunoglobulin G4, anti-(transforming growth factor beta) (human monoclonal GC-1008 heavy chain), disulfide with human monoclonal GC-1008 light chain, Dimer 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
01220132015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
UNLABELLED Transforming growth factor-β (TGF-β) signaling is involved in glioma development. The monoclonal antibody fresolimumab… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2015
Review
2015
Fresolimumab is an antibody capable of neutralizing all human isoforms of transforming growth factor beta (TGFβ) and has… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
BACKGROUND In advanced cancers, transforming growth factor-beta (TGFβ) promotes tumor growth and metastases and suppresses host… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Bone marrow fi brosis (BMF), in the myeloproliferative neoplasm (MPN) myelofi brosis (MF), is the result of a complex and yet not… (More)
  • table I
  • figure 1
Is this relevant?
2014
2014
Various important biological pathways are modulated by TGFβ isoforms; as such they are potential targets for therapeutic… (More)
  • figure 1
  • table I
  • figure 2
  • table II
  • table III
Is this relevant?
2013
2013
We evaluated a neutralizing anti-TGFβ antibody (GC1008) in cancer patients with malignant pleura mesothelioma (MPM). The goal of… (More)
Is this relevant?